First Heart Transplant

In December 1967, at Groote Schuur Hospital in Cape Town, the South African surgeon Christiaan Barnard led the team that performed the first successful transplant of a human heart into another person. The operation made headlines around the world and turned a long-standing experimental idea into a real clinical possibility. It also set off intense debate about how death should be defined and what limits medicine should observe.

The operation rested on decades of work by others. Surgeons had learned to join blood vessels in the early twentieth century, and the development of heart-lung bypass machines in the 1950s made it possible to stop a heart temporarily during surgery. In the United States, researchers such as Norman Shumway and Richard Lower at Stanford refined heart transplantation in dogs, showing that the technique was technically feasible. Barnard had trained in the United States and had experience with kidney transplants and animal experiments. The main obstacle remained rejection, since the body's immune system attacks foreign tissue, and early drugs to suppress it were crude and risky.

The patient was Louis Washkansky, a middle-aged grocer suffering from severe heart failure. His donor was a young woman, Denise Darvall, who had been fatally injured in a road accident. Her heart was removed after her death was declared, and it was implanted in Washkansky in an operation that lasted several hours and involved a sizable surgical team, including Barnard's brother Marius. The heart began working, and for a short time Washkansky seemed to be recovering. He died about eighteen days later from pneumonia, a complication linked to the immunosuppressive treatment that weakened his defenses.

Although Washkansky did not survive long, the operation was recognized as a landmark. Barnard became an international celebrity almost overnight. Within months, surgeons in the United States, Britain, France and elsewhere attempted their own heart transplants, and many early patients died within weeks or months. The enthusiasm faded, and several programs were abandoned in the early 1970s. Barnard's second patient, Philip Blaiberg, lived for well over a year, however, showing that longer survival was possible.

The real turning point came with improved immunosuppression, especially the introduction of cyclosporine in the early 1980s, which greatly raised survival rates. Heart transplantation then became an established treatment for end-stage heart disease. The procedure also pushed societies to adopt clearer criteria for brain death and to build systems for organ donation and allocation. Historians also note that the achievement came from a country under apartheid, and that the celebrated surgery took place against a backdrop of deep inequality in access to healthcare.